PT78289A - (1h-tetrazol-5-yl)2(1h)-quinolines and related compounds - Google Patents

(1h-tetrazol-5-yl)2(1h)-quinolines and related compounds

Info

Publication number
PT78289A
PT78289A PT78289A PT7828984A PT78289A PT 78289 A PT78289 A PT 78289A PT 78289 A PT78289 A PT 78289A PT 7828984 A PT7828984 A PT 7828984A PT 78289 A PT78289 A PT 78289A
Authority
PT
Portugal
Prior art keywords
tetrazol
quinolines
related compounds
compounds
quinolinone
Prior art date
Application number
PT78289A
Other languages
English (en)
Other versions
PT78289B (en
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of PT78289A publication Critical patent/PT78289A/pt
Publication of PT78289B publication Critical patent/PT78289B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Laminated Bodies (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
PT78289A 1983-03-25 1984-03-21 (1h-tetrazol-5-yl)2(1h)-quinolines and related compounds PT78289B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/478,965 US4735948A (en) 1983-03-25 1983-03-25 (1H-tetrazol-5-yl)-2(1H)-quinolinones and-naphthyridones and antiallergic use thereof

Publications (2)

Publication Number Publication Date
PT78289A true PT78289A (en) 1984-04-01
PT78289B PT78289B (en) 1986-04-22

Family

ID=23902120

Family Applications (1)

Application Number Title Priority Date Filing Date
PT78289A PT78289B (en) 1983-03-25 1984-03-21 (1h-tetrazol-5-yl)2(1h)-quinolines and related compounds

Country Status (17)

Country Link
US (1) US4735948A (pt)
EP (1) EP0120483B1 (pt)
JP (1) JPS59176276A (pt)
KR (1) KR900003650B1 (pt)
AT (1) ATE26276T1 (pt)
AU (1) AU562115B2 (pt)
CA (1) CA1241001A (pt)
DE (1) DE3462895D1 (pt)
DK (1) DK163238C (pt)
ES (1) ES530877A0 (pt)
GR (1) GR81908B (pt)
IE (1) IE57073B1 (pt)
IL (1) IL71319A (pt)
NO (1) NO841157L (pt)
NZ (1) NZ207581A (pt)
PT (1) PT78289B (pt)
ZA (1) ZA842065B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT79031B (en) * 1983-08-20 1986-08-22 Boots Co Plc Therapeutic agents
US5358949A (en) * 1986-03-05 1994-10-25 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives and salts thereof and anti-arrhythmic agents containing the carbostyril derivatives
US4916131A (en) * 1986-10-15 1990-04-10 Schering Corporation Naphthyridine derivatives and method for treating allergic reactions
US5037826A (en) * 1986-10-15 1991-08-06 Schering Corporation 1-substituted naphthyridine and pyridopyrazine derivatives
EP0267691A3 (en) * 1986-10-15 1989-08-23 Schering Corporation Use of 1-substituted naphthyridine and pyridopyrazine derivatives for the preparation of medicaments with immunosuppressor activity.
US5064837A (en) * 1989-11-13 1991-11-12 Schering Corporation 3-substituted-1-aryl-2(h)-quinolones and their pharmaceutical compositions
GB9026389D0 (en) * 1990-12-05 1991-01-23 Merck Sharp & Dohme Therapeutic agents
GB9125485D0 (en) * 1991-11-29 1992-01-29 Merck Sharp & Dohme Therapeutic agents
US5658924A (en) * 1992-12-01 1997-08-19 The Green Cross Corporation 1,8-naphthyridin-2-one derivative and use thereof
DE19727410A1 (de) * 1997-06-27 1999-01-07 Hoechst Schering Agrevo Gmbh 3-(5-Tetrazolylcarbonyl)-2-chinolone und diese enthaltende nutzpflanzenschützende Mittel
GB0316546D0 (en) 2003-07-15 2003-08-20 Novartis Ag Process for the manufacture of organic compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1444369A (en) * 1973-04-05 1976-07-28 Allen & Hanburys Ltd 1,8-naphthyridines
US3993656A (en) * 1974-11-19 1976-11-23 Merck & Co., Inc. 1,8-Naphthyridine compounds
US4035368A (en) * 1975-04-02 1977-07-12 Riker Laboratories, Inc. Substituted 3-(1H-tetrazol-5-yl)-quinoline compounds
US4350817A (en) * 1980-02-28 1982-09-21 American Home Products Corporation 4-Cl, Br or I-3-Carboxy or cyano-1,2-dihydro-2-oxo-1,8-naphthyridine derivatives
PT80533B (en) * 1984-05-29 1987-04-06 Pfizer Process for preparing quinolone inotropic agents

Also Published As

Publication number Publication date
DK165684D0 (da) 1984-03-23
ES8601963A1 (es) 1985-11-01
JPS59176276A (ja) 1984-10-05
EP0120483A1 (en) 1984-10-03
DK163238C (da) 1992-06-29
KR840008153A (ko) 1984-12-13
AU562115B2 (en) 1987-05-28
PT78289B (en) 1986-04-22
NZ207581A (en) 1987-01-23
ES530877A0 (es) 1985-11-01
IE57073B1 (en) 1992-04-22
CA1241001A (en) 1988-08-23
ZA842065B (en) 1984-10-31
DE3462895D1 (de) 1987-05-07
DK165684A (da) 1984-09-26
US4735948A (en) 1988-04-05
EP0120483B1 (en) 1987-04-01
AU2595284A (en) 1984-09-27
JPH0452273B2 (pt) 1992-08-21
DK163238B (da) 1992-02-10
IL71319A0 (en) 1984-06-29
GR81908B (pt) 1984-12-12
IL71319A (en) 1988-03-31
KR900003650B1 (ko) 1990-05-28
IE840720L (en) 1984-09-25
ATE26276T1 (de) 1987-04-15
NO841157L (no) 1984-09-26

Similar Documents

Publication Publication Date Title
NO881697D0 (no) Verktoeyenhet, verktoeydeler og fremgangsmaate for sammensetting av delene.
PT78289A (en) (1h-tetrazol-5-yl)2(1h)-quinolines and related compounds
ES8604520A1 (es) Procedimiento para preparar derivados de 2(1h)-piridona
AU539847B2 (en) 3,4,5-trihydroxypiperidine compounds
ES8705421A1 (es) Un procedimiento para la preparacion de 4-amino-2-fenil-quinolinas
DE3577087D1 (de) Durch tertiaeres alkyl monosubstituiertes toluylendiamin und derivate.
ZA842067B (en) (1h-tetrazol-5-yl)tetrazolo-(1,5-a)-quinolines and related compounds
DE3260714D1 (en) N-substituted 2-methylnaphthyl amides, their preparation and their use as fungicides
ATE41003T1 (de) Tetrazolothienopyridine.
DE3576076D1 (de) (tetrazolyl)thienopyridone.
FR2517679B1 (pt)
ES474052A1 (es) Procedimiento para la obtencion de 1,4-dihidropiridazinas 1-n-sustituidas.
ES8601154A1 (es) Procedimiento para la preparacion de compuestos de pirazina-bis(2-oxoglicina)antialergico.
IE820713L (en) Thiolphosphoric esteramide derivatives
EP0114389A3 (en) Substituted arylglyoxal derivatives
ES509743A0 (es) "mejoras en la fabricacion de puertas ignifugas revestidas de madera".
UA11771A1 (uk) КАЛІЄВА СІЛЬ N-СУКЦИH-d,l-ТРИПТОФАHУ, ЯКА МАЄ КАРДІОТОHІЧHУ ДІЮ
ES8801215A1 (es) Un procedimiento para la preparacion de nuevos derivados de benzazepina
ATE38030T1 (de) N-substituierte butyramide derivate.

Legal Events

Date Code Title Description
MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19941031